DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Bruckl WM, Wiest GH, Ficker JH.
Current status of erlotinib and gefitinib in palliative therapy for NSCLC – does the EGF-R mutation state have any significance.
Pneumologie 2010;
64: 727-735
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.